PROMEDIUS, an AI company focused on aging and metabolic diseases, presented three research abstracts at the American Society for Bone and Mineral Research (ASBMR 2025).

This achievement is significant as it provides international validation of the clinical and health economic value of our chest x-ray-based osteoporosis screening AI software, Osteo Signal.

The abstracts were presented by distinguished members of PROMEDIUS’s Scientific Advisory Board:

Prof. Stuart Silverman (Director of the Cedars Sinai Bone Center of Excellence, USA)

Prof. Manju Chandran (Senior Consultant and Director, Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital)

Osteoporosis often shows no symptoms, leading to missed diagnoses or recognition only after fractures occur. Osteoporotic fractures are difficult to treat, lower quality of life, and increase the overall socioeconomic burden on healthcare systems.

Our achievements at ASBMR 2025 serve as a signal of the global value of PROMEDIUS’s technology for Korea and other rapidly aging societies.

We will continue moving forward in fulfilling our mission 'Healthy Aging through AI'